Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study-Reference-Cited by-同舟云学术

Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study

Published:2023-10 Issue:4 Volume:165 Page:963-975.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Yarur Andres J.,Bruss Alexandra,Moosreiner Andrea,Beniwal-Patel Poonam,Nunez Lizbeth,Berens Brandon,Colombel Jean F.,Targan Stephan R.,Fox Caroline,Melmed Gil Y.,Abreu Maria T.,Deepak Parakkal

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

2. Ustekinumab as induction and maintenance therapy for Crohn’s disease;Feagan;N Engl J Med,2016

3. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin;Feagan;N Engl J Med,2005

4. Impact of obesity on short- and intermediate-term outcomes in inflammatory bowel diseases: pooled analysis of placebo arms of infliximab clinical trials;Singh;Inflamm Bowel Dis,2018

5. The body composition profile is associated with response to anti-TNF therapy in Crohn’s disease and may offer an alternative dosing paradigm;Ding;Aliment Pharmacol Ther,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-fiber, low-fat diet improves the symptoms and metabolic profile of patients with Crohn’s disease;2024-08-31

2. The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease;Current Treatment Options in Gastroenterology;2024-06-20

3. A High Visceral-to-Skeletal Muscle Area Ratio on Cross-Sectional Imaging Is Associated With Failure of Standard Ustekinumab Doses: A Multicenter Study;Clinical and Translational Gastroenterology;2024-06-01

4. Heavy arch: from inflammatory bowel diseases to metabolic disorders;Gut;2024-05-22

5. Quantification of Visceral Fat at the L5 Vertebral Body Level in Patients with Crohn’s Disease Using T2-Weighted MRI;Bioengineering;2024-05-22